Biogen Inc
(BUE:BIIB)
ARS
18434.5
-134.5 (-0.72%)
Market Cap: 28.46 Til
Enterprise Value: 33.64 Til
PE Ratio: 27.65
PB Ratio: 2.11
GF Score: 53/100 Biogen Inc Engage and Emerge Trials at CTAD Call Transcript
Release Date Price:
ARS4402
(+0.09%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot